Role of peroxisome proliferator-activated receptor gamma gene polymorphisms in type 2 diabetes mellitus patients of West Bengal, India

被引:15
|
作者
Pattanayak, Arup Kumar [1 ]
Bankura, Biswabandhu [1 ]
Balmiki, Nisha [1 ]
Das, Tapas Kumar [2 ]
Chowdhury, Subhankar [3 ]
Das, Madhusudan [1 ]
机构
[1] Univ Calcutta, Dept Zool, Kolkata, India
[2] Inst Post Grad Med Educ & Res, Dept Endocrinol, Kolkata, India
[3] Bagnan Rural Hosp, Howrah, W Bengal, India
关键词
Fasting sugar; Peroxisome proliferator activated receptor gamma gene; Type 2 diabetes mellitus; PPAR-GAMMA; PRO12ALA POLYMORPHISM; GLUCOSE-TOLERANCE; RESISTANCE; OBESITY; IMPACT; RISK; SUBSTITUTION; ASSOCIATION; POPULATION;
D O I
10.1111/jdi.12130
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/IntroductionPeroxisome proliferator activated receptor gamma (PPARG) is a nuclear hormone receptor of the ligand-dependent transcription factor involved in adipogenesis, and a molecular target of the insulin sensitizer, thiazolidinediones. The present study aimed to investigate whether the PPARG gene is associated with type 2 diabetes mellitus and its related traits within the population of West Bengal, India. Materials and MethodsThe study participants (200 type 2 diabetes mellitus and 200 normal individuals) were chosen randomly, and the variants were screened by direct sequencing. ResultsThe results showed that rs1801282 (odds ratio 0.66; 95% confidence interval 0.15-2.96; P=0.57) and rs3856806 (odds ratio 1.23; 95% confidence interval 0.73-2.06; P=0.44) variants of the PPARG gene were not associated with type 2 diabetes mellitus. ConclusionsThe results showed that the PPARG gene was not associated with type 2 diabetes mellitus in our study population. As the lack of association might come from the small sample size, further studies with larger sample size are required to verify the present observation.
引用
收藏
页码:188 / 191
页数:4
相关论文
共 50 条
  • [1] Inflammation in diabetes mellitus:: Role of peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-γ agonists
    Libby, Peter
    Plutzky, Jorge
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (4A): : 27B - 40B
  • [2] Role of peroxisome proliferator-activated receptors gene polymorphisms in type 2 diabetes and metabolic syndrome
    Dong, Chen
    Zhou, Hui
    Shen, Chong
    Yu, Lu-Gang
    Ding, Yi
    Zhang, Yong-Hong
    Guo, Zhi-Rong
    WORLD JOURNAL OF DIABETES, 2015, 6 (04) : 654 - 661
  • [3] The effect of the peroxisome proliferator-activated receptor gamma agonist, pioglitazone, on lipoprotein metabolism in patients with type 2 diabetes mellitus
    Nagashima, K
    Lopez, C
    Donovan, D
    Ngai, C
    Fontenez, N
    Holleran, S
    Ramakrishnan, R
    Ginsberg, HN
    DIABETES, 2004, 53 : A231 - A232
  • [4] Genetic polymorphisms in peroxisome proliferator-activated receptor γ are associated with Type 2 diabetes mellitus and obesity in the Korean population
    Moon, MK
    Cho, YM
    Jung, HS
    Park, YJ
    Yoon, KH
    Sung, YA
    Park, BL
    Lee, HK
    Park, KS
    Shin, HD
    DIABETIC MEDICINE, 2005, 22 (09) : 1161 - 1166
  • [5] Association of Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1 alpha Polymorphisms with Type 2 Diabetes Mellitus: A Meta-Analysis
    Yang, Y.
    Mo, X. B.
    Chen, S. F.
    Lu, X. F.
    Gu, D. F.
    CARDIOLOGY, 2010, 117 : 61 - 62
  • [6] The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity.
    Celi F.S.
    Shuldiner A.R.
    Current Diabetes Reports, 2002, 2 (2) : 179 - 185
  • [7] Adiponectin and peroxisome proliferator-activated receptor-γ gene polymorphisms and gene-gene interactions with type 2 diabetes
    Ye, Enling
    Yang, Hong
    Chen, Liangmiao
    Chen, Qingshou
    Sun, Mengli
    Lin, Zhenzhen
    Yu, Lechu
    Peng, Mengmeng
    Zhang, Chi
    Lu, Xuemian
    LIFE SCIENCES, 2014, 98 (01) : 55 - 59
  • [8] Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus
    Jay, Mollie A.
    Ren, Jun
    CURRENT DIABETES REVIEWS, 2007, 3 (01) : 33 - 39
  • [9] Effect of dual (alpha/gamma) peroxisome proliferator-activated receptor activator muraglitazar therapy in patients with type 2 diabetes mellitus
    Gastaldelli, Amalia
    Fernandez, Marianella
    Triplitt, Courtis
    Musi, Nicholas
    Di Gregorio, Emma
    Cersosimo, Eugenio
    Defronzo, Ralph A.
    DIABETES, 2008, 57 : A100 - A100
  • [10] Peroxisome proliferator-activated receptor gamma gene polymorphisms and risk of restenosis after coronary artery stenting in patients with diabetes
    Koch, W
    Jung, V
    Michou, E
    Gorchakova, O
    Tiroch, K
    von Beckerath, N
    Schömig, A
    Kastrati, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 77A - 77A